title: Increased human T-lymphotropic virus type II proviral load following highly active retroviral therapy in HIV-coinfected patients.
authors.forename: Edward L
authors.initials: EL
authors.lastname: Murphy
authors.forename: Robert M
authors.initials: RM
authors.lastname: Grant
authors.forename: Jerry
authors.initials: J
authors.lastname: Kropp
authors.forename: Adriano
authors.initials: A
authors.lastname: Oliveira
authors.forename: Tzong-Hae
authors.initials: TH
authors.lastname: Lee
authors.forename: Michael P
authors.initials: MP
authors.lastname: Busch
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D015491:HTLV-II Infections / Q000150:complications* / Q000188:drug therapy*; D015367:Human T-lymphotropic virus 2 / Q000302:isolation & purification*; D006801:Humans; D008875:Middle Aged; D011533:Proviruses / Q000302:isolation & purification*; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents